Management of Rheumatoid Arthritis.

Phase 1

• Conditions: Health Condition 1: null- Rheumatoid Arthritis

• Registration Number: CTRI/2018/01/011192
• Lead Sponsor: Central Council for Research in Homoeopathy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

i.Cases with score more than or equal to 6 as per ACR/EULAR 2010 criteria

ii.Patients with low and moderate activity of DAS 28- CRP score

iii.Patient not under any conventional treatment for RA except those on occasional painkillers

iv. Controlled cases of Diabetes, Hypertension and Hypothyroidism fulfilling above criteria

Exclusion Criteria

i. Cases having any other joint affection/Arthritis

ii.Pregnancy and Lactation

iii.RA patients with extensive joint deformity(more than or in 3 joints)

iv.Patients under conventional treatment for RA including DMARDs

v. Patient not giving consent

vi. Any patient not deemed fit by the investigator

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess and compare the changes in the DAS 28 CRP score from baseline, at 3rd, 6th, 9th and 12th month in Clinical improvement of Rheumatoid ArthritisTimepoint: Baseline, 3rd month, <br/ ><br>6th month, 9 month and end of 1 yr.

Secondary Outcome Measures

Name	Time	Method
To assess and compare the changes in activity profile and quality of life of Rheumatoid Arthritis patients using ACR 20 response criteriaTimepoint: Baseline, every month and at end of 1 yr.